Fengxia Shi

C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early

Chaochao Tan, Ying Huang, Fengxia Shi et al. · Journal of Medical Virology · 2020 · 598 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +15

Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial

Yang Liu, Yelei Guo, Zhiqiang Wu et al. · Cytotherapy · 2020 · 168 citations · Full text

Medicine, Oncology, Pharmacology +17

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

Hanren Dai, Wenying Zhang, Xiaolei Li et al. · OncoImmunology · 2015 · 166 citations · Full text

Medicine, Hematology, Immunology +17

Treatment of CD20-directed Chimeric Antigen Receptor-modified T cells in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an early phase IIa trial report

Wenying Zhang, Yao Wang, Yelei Guo et al. · Signal Transduction and Targeted Therapy · 2016 · 133 citations · Full text

Medicine, Immunology, Oncology +17

Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma

Yang Liu, Chunmeng Wang, Xiang Li et al. · Journal for ImmunoTherapy of Cancer · 2021 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17